切换至 "中华医学电子期刊资源库"

中华腔镜泌尿外科杂志(电子版) ›› 2023, Vol. 17 ›› Issue (06) : 653 -656. doi: 10.3877/cma.j.issn.1674-3253.2023.06.021

综述

钙和维生素D与肾结石形成关系的研究进展
方道成(), 胡媛媛   
  1. 201600 上海交通大学医学院附属松江医院泌尿外科
    201600 上海交通大学医学院附属松江医院全科医学科
  • 收稿日期:2022-06-23 出版日期:2023-12-01
  • 通信作者: 方道成

Research progress on the relationship between calcium, vitamin D and kidney stone formation

Daocheng Fang(), Yuanyuan Hu   

  • Received:2022-06-23 Published:2023-12-01
  • Corresponding author: Daocheng Fang
引用本文:

方道成, 胡媛媛. 钙和维生素D与肾结石形成关系的研究进展[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(06): 653-656.

Daocheng Fang, Yuanyuan Hu. Research progress on the relationship between calcium, vitamin D and kidney stone formation[J/OL]. Chinese Journal of Endourology(Electronic Edition), 2023, 17(06): 653-656.

肾结石的发病率很高,是泌尿外科的常见疾病之一[1]。最常见的结石成分是以钙盐为基础[2]。肾结石的形成受遗传和环境因素的影响[3-4]。饮食习惯属于后者,饮食因素可导致尿成分异常等[5],而较高的尿钙排泄是肾结石形成的重要危险因素[6]。因此,对钙盐结石者的营养建议包括增加液体、蔬菜和水果的摄入,平衡钙摄入,减少钠和动物蛋白的摄入等[7]。考虑到钙的吸收导致结石患者尿钙水平增加,理论上补充维生素D可能会增加钙的吸收和结石形成。虽然现有的关于膳食钙摄入的文献都支持钙饮食增加结石形成风险,但关于维生素D摄入和钙补充的数据不太一致[8-9]。因此,本研究旨在综述钙和维生素D与肾结石形成关系的研究现状及进展,为相关研究提供参考。

[1]
Hill AJ, Basourakos SP, Lewicki P, et al. Incidence of kidney stones in the united states: the continuous national health and nutrition examination survey[J]. J Urol, 2022, 207(4): 851-856.
[2]
王友铭,许长宝,王晓甫,等. 河南省泌尿系结石住院患者流行病学特点及分析[J]. 临床泌尿外科杂志, 2021, 36(6): 458-463.
[3]
Ferraro PM, Bargagli M. Dietetic and lifestyle recommendations for stone formers[J]. Arch Esp Urol, 2021, 74(1): 112-122.
[4]
Howles SA, Thakker RV. Genetics of kidney stone disease[J]. Nat Rev Urol, 2020,17(7): 407-421.
[5]
Ferraro PM, Bargagli M, Trinchieri A, et al. Risk of kidney stones: influence of dietary factors, dietary patterns, and vegetarian-vegan diets[J]. Nutrients, 2020, 12(3): 779.
[6]
方道成,谷江. 维生素D、高钙尿和肾结石的关系探讨[J]. 现代临床医学, 2019, 45(6): 466-469.
[7]
Skolarikos A, Straub M, Knoll T, et al. Metabolic evaluation and recurrence prevention for urinary stone patients: EAU guidelines[J]. Eur Urol, 2015, 67(4): 750-763.
[8]
Letavernier E, Daudon M. Vitamin D, hypercalciuria and kidney stones[J]. Nutrients, 2018, 10(3): 366.
[9]
Ferraro PM, Taylor EN, Gambaro G, et al. Vitamin D intake and the risk of incident kidney stones[J]. J Urol, 2017, 197(2): 405-410.
[10]
Hart NH, Newton RU, Tan J, et al. Biological basis of bone strength: anatomy, physiology and measurement[J]. J Musculoskelet Neuronal Interact, 2020, 20(3): 347-371.
[11]
Christakos S, Dhawan P, Verstuyf A, et al. Vitamin D: metabolism, molecular mechanism of action, and pleiotropic effects[J]. Physiol Rev, 2016, 96(1): 365-408.
[12]
De Paolis E, Scaglione GL, De Bonis M, et al. CYP24A1 and SLC34A1 genetic defects associated with idiopathic infantile hypercalcemia: from genotype to phenotype[J]. Clin Chem Lab Med, 2019, 57(11): 1650-1667.
[13]
Shavit L, Chen L, Ahmed F, et al. Selective screening for distal renal tubular acidosis in recurrent kidney stone formers: initial experience and comparison of the simultaneous furosemide and fludrocortisone test with the short ammonium chloride test[J]. Nephrol Dial Transplant, 2016, 31(11): 1870-1876.
[14]
Gambaro G, Croppi E, Coe F, et al. Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement[J]. J Nephrol, 2016, 29(6): 715-734.
[15]
Bargagli M, Dhayat N A, Anderegg M, et al. Urinary lithogenic risk profile in ADPKD patients treated with tolvaptan[J]. Clin J Am Soc Nephrol, 2020, 15(7): 1007-1014.
[16]
Downie ML, Alexander RT. Molecular mechanisms altering tubular calcium reabsorption[J]. Pediatr Nephrol, 2021, 37(4): 707-718.
[17]
Martinez GM, Trincado AP, Perez FL, et al. A comparison of induced effects on urinary calcium by thiazides and different dietary salt doses: implications in clinical practice[J]. Nefrologia (Engl Ed), 2019, 39(1): 73-79.
[18]
Edwards NA, Hodgkinson A. Metabolic studies in patients with idiopathic hypercalciuria[J]. Clin Sci, 1965, 29(1): 143-157.
[19]
Bargagli M, Arena M, Naticchia A, et al. The role of diet in bone and mineral metabolism and secondary hyperparathyroidism[J]. Nutrients, 2021,13(7): 13(7):2328..
[20]
Fleet JC. The role of vitamin D in the endocrinology controlling calcium homeostasis[J]. Mol Cell Endocrinol, 2017,453:36-45.
[21]
Tan R, Lee C, Dimke H, et al. The role of calcium-sensing receptor signaling in regulating transepithelial calcium transport[J]. Exp Biol Med (Maywood), 2021, 246(22): 2407-2419.
[22]
Zerwekh JE, Reed BY, Heller HJ, et al. Normal vitamin D receptor concentration and responsiveness to 1, 25-dihydroxyvitamin D3 in skin fibroblasts from patients with absorptive hypercalciuria[J]. Miner Electrolyte Metab, 1998, 24(5): 307-313.
[23]
Miao D, Goltzman D. Probing the scope and mechanisms of calcitriol actions using genetically modified mouse models[J]. JBMR Plus, 2021, 5(1): e10434.
[24]
Imani D, Razi B, Khosrojerdi A, et al. Vitamin D receptor gene polymorphisms and susceptibility to urolithiasis: a meta-regression and meta-analysis[J]. BMC Nephrol, 2020, 21(1): 263.
[25]
李心,李康健,申吉弘,等. 维生素D受体基因单核苷酸多态性位点FokⅠ和ApaⅠ与特发性低枸橼酸尿症的关系[J]. 中华实验外科杂志, 2019, 36(7): 1204-1207.
[26]
Hu H, Zhang J, Lu Y, et al. Association between circulating vitamin d level and urolithiasis: a systematic review and meta-analysis[J]. Nutrients, 2017, 9(3): 301.
[27]
Kim WT, Kim YJ, Yun SJ, et al. Role of 1, 25-dihydroxy vitamin D3 and parathyroid hormone in urinary calcium excretion in calcium stone formers[J]. Yonsei Med J, 2014, 55(5): 1326-1332.
[28]
Taylor EN, Hoofnagle AN, Curhan GC. Calcium and phosphorus regulatory hormones and risk of incident symptomatic kidney stones[J]. Clin J Am Soc Nephrol, 2015, 10(4): 667-675.
[29]
Mateo RCI, Ortiz R, Rosen HN. Bisphosphonates for the treatment of calcitriol-induced hypercalcemia[J]. AACE Clin Case Rep, 2019, 5(5): e316-e320.
[30]
Meyer MB, Pike JW. Mechanistic homeostasis of vitamin D metabolism in the kidney through reciprocal modulation of Cyp27b1 and Cyp24a1 expression[J]. J Steroid Biochem Mol Biol, 2020, 196: 105500.
[31]
Melo TL, Esper P, Zambrano LI, et al. Expression of vitamin D receptor, CYP27B1 and CYP24A1 hydroxylases and 1,25-dihydroxyvitamin D3 levels in stone formers[J]. Urolithiasis, 2020, 48(1): 19-26.
[32]
Molin A, Baudoin R, Kaufmann M, et al. CYP24A1 mutations in a cohort of hypercalcemic patients: evidence for a recessive trait[J]. J Clin Endocrinol Metab, 2015, 100(10): E1343-E1352.
[33]
Kang SJ, Lee R, Kim HS. Infantile hypercalcemia with novel compound heterozygous mutation in SLC34A1 encoding renal sodium-phosphate cotransporter 2a: a case report[J]. Ann Pediatr Endocrinol Metab, 2019, 24(1): 64-67.
[34]
Cormick G, Belizan JM. Calcium intake and health[J]. Nutrients, 2019, 11(7): 1606.
[35]
Coe FL, Favus MJ, Crockett T, et al. Effects of low-calcium diet on urine calcium excretion, parathyroid function and serum 1,25(OH)2D3 levels in patients with idiopathic hypercalciuria and in normal subjects[J]. Am J Med, 1982, 72(1): 25-32.
[36]
柯卓丽,孙丹丹,陈雪莲. 泌尿系结石患者饮食营养认知的调查分析[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2020, 14(3): 208-211.
[37]
Saponaro F, Marcocci C, Apicella M, et al. Hypomagnesuria is associated with nephrolithiasis in patients with asymptomatic primary hyperparathyroidism[J]. J Clin Endocrinol Metab, 2020, 105(8): dgaa233.
[38]
Curhan GC, Willett WC, Rimm EB, et al. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones[J]. N Engl J Med, 1993, 328(12): 833-838.
[39]
Curhan GC, Willett WC, Speizer FE, et al. Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women[J]. Ann Intern Med, 1997, 126(7): 497-504.
[40]
Domrongkitchaiporn S, Sopassathit W, Stitchantrakul W, et al. Schedule of taking calcium supplement and the risk of nephrolithiasis[J]. Kidney Int, 2004, 65(5): 1835-1841.
[41]
Prentice RL, Pettinger MB, Jackson RD, et al. Health risks and benefits from calcium and vitamin D supplementation: women's health initiative clinical trial and cohort study[J]. Osteoporos Int, 2013, 24(2): 567-580.
[42]
Malihi Z, Wu Z, Stewart AW, et al. Hypercalcemia, hypercalciuria, and kidney stones in long-term studies of vitamin D supplementation: a systematic review and meta-analysis[J]. Am J Clin Nutr, 2016, 104(4): 1039-1051.
[43]
Lappe J, Watson P, Travers-Gustafson D, et al. Effect of Vitamin D and calcium supplementation on cancer incidence in older women: a randomized clinical trial[J]. JAMA, 2017, 317(12): 1234-1243.
[44]
Johri N, Jaeger P, Ferraro PM, et al. Vitamin D deficiency is prevalent among idiopathic stone formers, but does correction pose any risk?[J]. Urolithiasis, 2017, 45(6): 535-543.
[45]
Malihi Z, Lawes C, Wu Z, et al. Monthly high-dose vitamin D supplementation does not increase kidney stone risk or serum calcium: results from a randomized controlled trial[J]. Am J Clin Nutr, 2019, 109(6): 1578-1587.
[1] 毛书雷, 张元海, 王杰, 倪良方, 王新刚, 邹雁, 王荣娟, 吴军梅, 张建芬. 区域性静脉灌注葡萄糖酸钙治疗手指氢氟酸烧伤的临床疗效和安全性分析[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(05): 386-392.
[2] 易柏成, 李旭光, 王容容, 王新璇. 数字化3D打印导板应用于上前牙钙化根管治疗2例[J/OL]. 中华口腔医学研究杂志(电子版), 2024, 18(06): 385-390.
[3] 石兵, 张智, 陈金海, 唐文. 基于电磁跟踪和手术导航系统的实时超声引导下两种经皮肾盏穿刺方法的应用[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 572-578.
[4] 王铭池, 梁乐琦, 刘永达. 基于NHANES数据库分析血脂与肾结石之间的关系[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(05): 485-490.
[5] 方道成, 唐春华, 胡媛媛. 肠道菌群对草酸钙肾结石形成的影响[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(05): 509-513.
[6] 董大红, 周明虎, 李芝朋, 许正峰. 碳青霉烯类抗生素联合呼吸机治疗肺部感染的临床疗效分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 793-796.
[7] 燕红玲, 王岩岩, 陈树斌. PCT、NLR联合LUBS预测ICU CRKP致呼吸机相关肺炎撤机及预后分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(04): 617-620.
[8] 白若靖, 郭军. 维生素D对肺部疾病临床意义的研究进展[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(04): 659-662.
[9] 甘志新, 胡雍军, 肖晶, 胡明冬. 降钙素原在脓毒血症与肺部感染中的研究进展[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(04): 663-666.
[10] 赵月, 田坤, 张宗明, 郭震天, 刘立民, 张翀, 刘卓. 降钙素原对老年急性重度胆囊炎发生的预测价值[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 801-806.
[11] 周敏, 徐阳, 胡莹, 黄先凤. 维持性血液透析患者血清β-CTX、N-MID 和PICP 与冠状动脉钙化的关系及其诊断价值[J/OL]. 中华肾病研究电子杂志, 2024, 13(05): 256-260.
[12] 刘思含, 张静. 老年人血清铁与C 反应蛋白的比值及25-羟基维生素D3 与肾功能受损的关系研究[J/OL]. 中华肾病研究电子杂志, 2024, 13(05): 268-272.
[13] 房桂彬, 肖进, 傅光涛, 郑秋坚. 老年髋部骨折患者术后1年行走能力的影响因素分析[J/OL]. 中华老年骨科与康复电子杂志, 2024, 10(05): 273-280.
[14] 韩俊岭, 王刚, 马厉英, 连颖, 徐慧. 维生素D 联合匹维溴铵治疗腹泻型肠易激综合征患者疗效及对肠道屏障功能指标的影响研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 560-564.
[15] 沈炎, 张俊峰, 唐春芳. 预后营养指数结合血清降钙素原、胱抑素C及视黄醇结合蛋白对急性胰腺炎并发急性肾损伤的预测价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 536-540.
阅读次数
全文


摘要